Thomas Hope, MD
University of California, San Francisco
13
13
7
N/A
0
11
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Kevin A camphausen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Rahul Aggarwal, MD
University of California, San Francisco
Shared therapeutic areas:
Worked with same sponsors:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
James L Gulley, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Nancy Lee, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Imaging of Solid Tumors Using FAP-2286
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients
18F-Fluorocholine for the Detection of Parathyroid Adenomas
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
Evaluation of Rectal Cancer Treatment Response Using PET/MRI
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer
Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
All 13 trials loaded